Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
How Horizon Therapeutics Will Strengthen Amgen's Portfolio
02:32pm, Wednesday, 14'th Dec 2022
Amgen Inc. ( AMGN , Financial) shook up the market on Monday when the company announced it had agreed to purchase Horizon Therapeutics PLC ( HZNP , Financial) for $27.8 billion.
Amgen to Buy Horizon Therapeutics: ETFs to Bet On
12:48pm, Tuesday, 13'th Dec 2022
Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from t
Amgen: 'Winner' For Horizon
09:12am, Tuesday, 13'th Dec 2022
Amgen has become the winner in the Horizon Therapeutics sale process. The deal comes at a full price, offset by synergy estimates and pipeline additions.
Jim Cramer says three key deals helped the market rally on Monday
07:22pm, Monday, 12'th Dec 2022
Cramer explained how three corporate deals announced on Monday helped push stocks up.
Amgen set to acquire Horizon Therapeutics in $26.4 billion deal
04:40pm, Monday, 12'th Dec 2022
Yahoo Finance anchors Seana Smith and Jared Blikre discuss Amgen set to acquire Horizon Therapeutics for more than $26 billion as the company dives deeper into rare disease treatment.
Private equity firms ramp up M&A pursuits
03:25pm, Monday, 12'th Dec 2022
Dan Primack, business editor at Axios, joins 'Power Lunch' to discuss three major M&A positions underway, potential increases in private equity M&A deals and what sectors are primed for acquisition.
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
03:05pm, Monday, 12'th Dec 2022
Amgen Inc. said Monday that it's acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
Billionaire John Paulson is reportedly set to reap $500 million from Amgen's huge deal to acquire Horizon Therapeutics
02:55pm, Monday, 12'th Dec 2022
Horizon is the largest disclosed holding of John Paulson's family office Paulson & Co., according to Forbes.
Horizon Therapeutics Acquisition: A Good Deal For Amgen Investors
02:35pm, Monday, 12'th Dec 2022
Amgen is acquiring Horizon Therapeutics for $27.8 billion. The deal immediately adds $3.7 billion in annual revenue.
Amgen to acquire Horizon Therapeutics for $27.8 billion
01:53pm, Monday, 12'th Dec 2022
Yahoo Finance's Anjalee Khemlani explains news of a major biotech merger as Amgen is set to acquire Horizon Therapeutics.
The Return of "Merger Monday"
01:32pm, Monday, 12'th Dec 2022
Two major deals in the biotech and software industry were inked this weekend.
What Amgen Is Getting Through The Acquisition Of Horizon Therapeutics
12:44pm, Monday, 12'th Dec 2022
Amgen Inc. will acquire Horizon Therapeutics Public Limited Company for $116.50 per share in an all-cash transaction. This is a suboptimal exit for Horizon shareholders, but we should acknowledge the
Busy Week Highlighted by Next Fed Rate Move
12:02pm, Monday, 12'th Dec 2022
Consensus is currently for a 50 basis point (bps) hike mid-week, which will bring the Fed funds rate over +4% for the first time in 15 years.
Wall Street Awaits Key Fed FOMC Decision
12:02pm, Monday, 12'th Dec 2022
Wall Street Awaits Key Fed FOMC Decision
Billionaire John Paulson Stands To Make $500 Million From Horizon's Sale To Amgen
11:40am, Monday, 12'th Dec 2022
Hedge fund billionaire John Paulson stands to reap about $500 million if Amgen's deal for Horizon goes through. It's the latest victory for the man who shot to fame for his big bet during the subprime
